Gynura bicolor (Willd.) DC., is used in folk recipes for the treatment of diabetes mellitus in Jiangsu, Zhejiang and Sichuan province in the south of China. A previous pharmacological study proved that the plant showed significant hypoglycemic activity on normal and alloxan-diabetic mice. In this study, two terpenes, four megastigmane-type norisoprenoids and two glycosides were isolated from the aqueous ethanolic extract of the aerial parts of Gynura bicolor and characterized mainly by NMR spectroscopy and mass spectrometry. These compounds were isolated for the first time from this plant, and no evidence could be found for the previous reported presence of megastigmane-type norisoprenoids in the genus Gynura.
The genus Gynura belongs to the family Asteraceae, comprising approximately 40 species mainly distributed in Asia, Africa and Australia, of which 10 species were recorded in the south of China [1] . In the literature, the presence of some interesting components in plants of the Gynura genus, such as volatiles [2, 3] , phenolics [4a] , chromanes [4b] , chromanones [4c,d] , coumarins [4e], steroids [4d,f] and cerebrosides [5-7a] , together with pyrrolizidine alkaloids [7b -10] , which are hepatotoxic and could cause hepatic veno-occlusive disease [11a] , is reported.
Gynura bicolor, which has been cultivated as a popular vegetable, is not only known to be nutritive but is also used for the treatment of diabetes in the south of China. Our previous pharmacological tests proved that the ethyl acetate and n-butanol extracts of aerial parts of the plant had significant effects on lowering blood glucose level in normal and alloxan-diabetic mice [11b]. To our knowledge, only three studies investigated the volatiles [3a-c] and one research reported on some anthocyanins [11c] from this plant. In the present study, two terpenes, four megastigmane-type norisoprenoids and two glycosides were obtained by combined chromatographic methods from the aqueous ethanolic extract of the aerial parts of Gynura bicolor. By comparison of their 1 H, 13 C NMR and ESI-MS spectral data with those reported, these isolated compounds (1) (2) (3) (4) (5) (6) (7) (8) were unambiguously identified as: ficusic acid (1) [12a] , loliolide (2) 
. Noteworthy, the 1 H and 13 C NMR spectral data of compound 2, which were in correspondence with loliolide [12b], were also nearly identical with those of a compound, named pubinernoid A, which was isolated from Schisandra pubescens var. pubinervis [14c]. The structure proposal for pubinernoid A, with the same molecular formula as loliolide, was (4S*,6R*)-4-hydroxy-4, 8,8-trimethyl-9-oxabicyclo[4.2.1] non-1-en-3-one, with an atypical value of 183.2 ppm for the chemical shift of the keto group. However, upon comparing GC-MS spectral data with data available in the WILEY6N database, compound 2 was identified as loliolide. Senecioneae, belonging to the Asteraceae family [14d] . In this study, chemical constituents of G. bicolor from the same tribe are assigned as terpenes (1-2), megastigmane-type norisoprenoids (3-6) and glycosides (6) (7) (8) . It should be noted that all these compounds were isolated for the first time from this plant, and no evidence could be found of the previous reported presence of megastigmanetype norisoprenoids in the genus Gynura. Roseoside (6) was firstly isolated from Vinca rosea in 1974 [14e], and together with their stereoisomers, they were found in many plant sources. It is interesting to note that (6S,9R)-roseoside, which is an isomer of (6S,9S)-roseoside (6) currently isolated, has previously been shown to increase insulin secretion from INS-1 β-cells [14f]. Vomifoliol (4), the aglycone of an isomer of (6S,9S)-roseoside (6), and its analogue, dehydrovomifoliol (3), were identified for the first time in the fruits from Vitis vinifera [15] . Boscialin (5) can be regarded as a reduced analogue of dehydrovomifoliol (3). The occurrence of C13type norisoprenoids in Gynura bicolor, as demonstrated in this paper, is noteworthy.
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extract was coated on silica gel, and then successively extracted with n-hexane, CH 2 Cl 2 , EtOAc and MeOH to give four fractions. The CH 2 Cl 2 extract (3.4 g) was further fractionated by column chromatography over silica gel, eluted with CH 2 Cl 2 containing increasing concentrations of MeOH to obtain seven fractions (Fr. B1-B7). Fr. B2 (600 mg) was fractionated with an automatic flash chromatography system on a reversed-phase column (C-18) eluted by a gradient of water and MeOH (50-100%) to get four fractions (Fr. B2-1~4). Fr. B2-1 (248 mg) and B2-2 (175 mg) were further subjected to column chromatography over MCI gel CHP20P eluted by a gradient of water and MeOH (20-100% C1-C5). Fr. C2 (724 mg) was further separated with automatic flash chromatography on a reverse phase column (C-18) eluted with a gradient of water and MeOH (20-100%). Four fractions (Fr. C2-1~4) were obtained and Fr. C2-2 (510 mg) was subjected to chromatography on a silica gel column eluted with a CHCl 3 /MeOH gradient (100:1 to 6:1) to give six fractions (C2-2-1~6). The C2-2-3 fraction (12 mg) and C2-2-4 fraction (20 mg) were finally purified by prep-HPLC eluted with MeOH/H 2 O (36:64) to yield pure (6S,9S)-roseoside 6 (2.2 mg) and benzyl-β-D-glucopyranoside 7 (1.3 mg). Fr. C3 ( 
